In addition, to providing a better understanding of the mechanisms that underpin BRIP1‐mediated tumour cell invasion, this study has validated BRIP1 as a target gene that can be used to design efficient therapeutic strategies against BC. The gene discussed is BRIP1; the disease is neoplasm.